Sequential Intravesical Gemcitabine and Docetaxel for the Salvage Treatment of Non-Muscle Invasive Bladder Cancer

Abstract

Sequential dual intravesical gemcitabine and docetaxel can salvage some patients in a challenging NMIBC cohort.